search all topics discussed by SAGE since 1997 ( you may use single or double quotes to group terms ie "yellow fever" measles 'pertussis control' )
Report from The WHO Department of Immunization, Vaccines and Biologicals.
Report from The GAVI Alliance.
Report from The Global Advisory Committee on Vaccine Safety (GACVS).
Report from The Implementation Research Advisory Committee (IVIR-AC).
Report from The Immunization Practices Advisory Committee (IPAC).
Report from The Product Development for Vaccines Advisory Committee(PDVAC).
Report from The Expert Committee on Biological Standardization (ECBS).
Polio eradication : SAGE reviewed all readiness criteria for the global withdrawal of type 2 oral poliovirus vaccine (OPV2) as well as type 2 vaccine-derived poliovirus (VDPV2) epidemiology, in order to assess whether to confirm April 2016 as the date for the globally coordinated withdrawal of OPV2 by switching from use of trivalent OPV (tOPV) to bivalent OPV (bOPV).
Ebola vaccines and vaccination:SAGE reviewed: available information on epidemiology, risk factors and transmission patterns of Ebola virus disease (EVD); the status of vaccine development; preliminary results from the most advanced vaccine candidates; preparations for vaccine deployment; and projections of the impact of vaccination in different epidemiological scenarios.
Measles and rubella:SAGE reaffirmed its previous assessment that the 2015 global measles control milestones as well as regional measles and rubella elimination goals are off-track (except in the Americas). SAGE supported the conduct of a midterm review of the global measles and rubella strategic plan to better understand why targets are being missed and propose measures to accelerate progress.
RTS,S/AS01 malaria vaccine.
Global Vaccine Action Plan (GVAP) 2015: assessment of progress and recommendations.
Report on activities from international immunization partners (UNICEF, MSF).